271 related articles for article (PubMed ID: 30577875)
1. Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.
Welters A; Meissner T; Grulich-Henn J; Fröhlich-Reiterer E; Warncke K; Mohnike K; Blankenstein O; Menzel U; Datz N; Bollow E; Holl RW
Orphanet J Rare Dis; 2018 Dec; 13(1):230. PubMed ID: 30577875
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism.
Arya VB; Senniappan S; Demirbilek H; Alam S; Flanagan SE; Ellard S; Hussain K
PLoS One; 2014; 9(5):e98054. PubMed ID: 24840042
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine in Congenital Hyperinsulinism - A Case Report.
Khawash P; Hussain K; Flanagan SE; Chatterjee S; Basak D
J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):151-4. PubMed ID: 26316440
[TBL] [Abstract][Full Text] [Related]
4. The difficult management of persistent, non-focal congenital hyperinsulinism: A retrospective review from a single, tertiary center.
Rasmussen AG; Melikian M; Globa E; Detlefsen S; Rasmussen L; Petersen H; Brusgaard K; Rasmussen AH; Mortensen MB; Christesen HT
Pediatr Diabetes; 2020 May; 21(3):441-455. PubMed ID: 31997554
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of 114 patients with congenital hyperinsulinism.
Meissner T; Wendel U; Burgard P; Schaetzle S; Mayatepek E
Eur J Endocrinol; 2003 Jul; 149(1):43-51. PubMed ID: 12824865
[TBL] [Abstract][Full Text] [Related]
6. Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.
Salomon-Estebanez M; Flanagan SE; Ellard S; Rigby L; Bowden L; Mohamed Z; Nicholson J; Skae M; Hall C; Craigie R; Padidela R; Murphy N; Randell T; Cosgrove KE; Dunne MJ; Banerjee I
Orphanet J Rare Dis; 2016 Dec; 11(1):163. PubMed ID: 27908292
[TBL] [Abstract][Full Text] [Related]
7. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism.
Beltrand J; Caquard M; Arnoux JB; Laborde K; Velho G; Verkarre V; Rahier J; Brunelle F; Nihoul-Fékété C; Saudubray JM; Robert JJ; de Lonlay P
Diabetes Care; 2012 Feb; 35(2):198-203. PubMed ID: 22190679
[TBL] [Abstract][Full Text] [Related]
8. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of medically-refractory hyperinsulinism.
Zobel MJ; McFarland C; Ferrera-Cook CT; Padilla BE
Am J Surg; 2020 Jun; 219(6):947-951. PubMed ID: 31757439
[TBL] [Abstract][Full Text] [Related]
10. Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy.
Tyrrell VJ; Ambler GR; Yeow WH; Cowell CT; Silink M
J Paediatr Child Health; 2001 Oct; 37(5):483-8. PubMed ID: 11885714
[TBL] [Abstract][Full Text] [Related]
11. The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes.
Jack MM; Greer RM; Thomsett MJ; Walker RM; Bell JR; Choong C; Cowley DM; Herington AC; Cotterill AM
Clin Endocrinol (Oxf); 2003 Mar; 58(3):355-64. PubMed ID: 12608942
[TBL] [Abstract][Full Text] [Related]
12. Adjustment of octreotide dose given via insulin pump based on continuous glucose monitoring (CGM) in a child with congenital hyperinsulinism.
Tiberi V; Cherubini V; Iannilli A; Gasparini F; Marino M
J Pediatr Endocrinol Metab; 2023 Aug; 36(8):803-807. PubMed ID: 37248699
[TBL] [Abstract][Full Text] [Related]
13. Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism.
Ros-Pérez P; Golmayo L; Cilleruelo ML; Gutiérrez C; Celaya P; Lacámara N; Martínez-Badás I; Güemes M; Argente J
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):947-950. PubMed ID: 32634108
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic exocrine and endocrine function after pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy.
Cade A; Walters M; Puntis JW; Arthur RJ; Stringer MD
Arch Dis Child; 1998 Nov; 79(5):435-9. PubMed ID: 10193259
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
Laimon W; Aboelenin HM; El Tantawi NT
Pediatr Diabetes; 2021 May; 22(3):388-399. PubMed ID: 33528087
[TBL] [Abstract][Full Text] [Related]
16. Current and Emerging Agents for the Treatment of Hypoglycemia in Patients with Congenital Hyperinsulinism.
De Cosio AP; Thornton P
Paediatr Drugs; 2019 Jun; 21(3):123-136. PubMed ID: 31218604
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism and neurological outcome in congenital hyperinsulinism.
Ludwig A; Ziegenhorn K; Empting S; Meissner T; Marquard J; Holl R; ; Mohnike K
Semin Pediatr Surg; 2011 Feb; 20(1):45-9. PubMed ID: 21186004
[TBL] [Abstract][Full Text] [Related]
18. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy.
Chen Q; Chen Y; Wang X; Yang H; Zhang Y; Liu X; Yan Y; Wei H
J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):119-123. PubMed ID: 32482020
[TBL] [Abstract][Full Text] [Related]
20. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
Durmaz E; Flanagan SE; Parlak M; Ellard S; Akcurin S; Bircan I
J Clin Res Pediatr Endocrinol; 2014; 6(2):119-21. PubMed ID: 24932607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
